Sharon Shacham
Director/Board Member at ACRIVON THERAPEUTICS, INC.
Net worth: 151 119 $ as of 2024-05-30
Sharon Shacham active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ACRIVON THERAPEUTICS, INC. | Director/Board Member | 2020-09-30 | - |
| Independent Dir/Board Member | 2020-09-30 | - |
Career history of Sharon Shacham
Former positions of Sharon Shacham
| Companies | Position | Start | End |
|---|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Director/Board Member | 2013-05-20 | 2015-01-20 |
| Chief Tech/Sci/R&D Officer | 2010-12-26 | 2021-05-02 | |
| Founder | 2008-12-21 | 2021-05-02 | |
| Corporate Officer/Principal | 2008-12-21 | - | |
| President | 2014-08-11 | 2021-05-02 | |
EPIX Pharmaceuticals, Inc.
 EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | Corporate Officer/Principal | 1999-12-31 | 2009-03-31 |
Predix Pharmaceuticals, Inc.
 Predix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Predix Pharmaceuticals, Inc. develops novel drugs and other related products. It is a clinical stage drug development company that uses proprietary discovery and lead optimization engine to develop novel drugs for G-protein coupled receptor (GPCR) and ion channel targets. The company was founded by Silvia Noiman, Haim Aviv, Oren M. Becker and Oren M. Ramot in September, 2002 and is headquartered in Woburn, MA. | Corporate Officer/Principal | - | - |
Training of Sharon Shacham
| Tel-Aviv University | Doctorate Degree |
Statistics
International
| United States | 5 |
| Israel | 2 |
Operational
| Corporate Officer/Principal | 3 |
| Director/Board Member | 2 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| KARYOPHARM THERAPEUTICS INC. | Health Technology |
| ACRIVON THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | Health Technology |
Predix Pharmaceuticals, Inc.
Predix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Predix Pharmaceuticals, Inc. develops novel drugs and other related products. It is a clinical stage drug development company that uses proprietary discovery and lead optimization engine to develop novel drugs for G-protein coupled receptor (GPCR) and ion channel targets. The company was founded by Silvia Noiman, Haim Aviv, Oren M. Becker and Oren M. Ramot in September, 2002 and is headquartered in Woburn, MA. | Health Technology |
- Stock Market
- Insiders
- Sharon Shacham
- Experience
